Esra Kaytan
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Surgery
- Otorhinolaryngology top 5%
- Pathology and Forensic Medicine top 10%
- Co-authors
- İnci̇ AyanErkan TopuzNuri Faruk AykanSüleyman AlıcıBurak SakarAdnan AydınerFaruk TaşYeşim Eralp
- Topics
- Head and Neck Cancer Studies (4 papers)Sarcoma Diagnosis and Treatment (3 papers)Viral-associated cancers and disorders (3 papers)
- Partner nations
- Türkiye
In The Last Decade
Esra Kaytan
16 papers receiving 468 citations
Peers
Comparison fields: 5 of 48
- Oncology 240
- Pulmonary and Respiratory Medicine 189
- Surgery 174
- Otorhinolaryngology 116
- Pathology and Forensic Medicine 115
Countries citing papers authored by Esra Kaytan
This map shows the geographic impact of Esra Kaytan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esra Kaytan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esra Kaytan more than expected).
Fields of papers citing papers by Esra Kaytan
This network shows the impact of papers produced by Esra Kaytan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esra Kaytan. The network helps show where Esra Kaytan may publish in the future.
Co-authorship network of co-authors of Esra Kaytan
This figure shows the co-authorship network connecting the top 25 collaborators of Esra Kaytan. A scholar is included among the top collaborators of Esra Kaytan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esra Kaytan. Esra Kaytan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Survival outcomes in aggressive non-Hodgkin's lymphoma according to the International Prognostic Index. | 0 |
| 2 | The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer. | 0 |
| 3 | 45 | |
| 4 | Prognostic significance of hemoglobin concentration in nasopharyngeal carcinoma: does treatment-induced anemia have negative effect? | 6 |
| 5 | 15 | |
| 6 | 13 | |
| 7 | 14 | |
| 8 | 84 | |
| 9 | 130 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 25 | |
| 15 | 7 | |
| 16 | 90 | |
| 17 | 13 | |
| 18 | 27 |
About Esra Kaytan
Esra Kaytan is a scholar working on Otorhinolaryngology, Oncology and Hepatology, having authored 18 papers that have together received 480 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Otorhinolaryngology (116 citations), Oncology (240 citations) and Pathology and Forensic Medicine (115 citations). Esra Kaytan has collaborated with scholars based in Türkiye. Frequent co-authors include İnci̇ Ayan, Erkan Topuz, Nuri Faruk Aykan, Süleyman Alıcı, Burak Sakar, Adnan Aydıner, Faruk Taş, Yeşim Eralp, Mert Başaran and Haluk Onat. Their work appears in journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.